2,736
edits
mNo edit summary |
|||
Line 31: | Line 31: | ||
'''Dissociatives''' | '''Dissociatives''' | ||
* Ketamine a synthetic anaesthesia, which globally, is the most prescribed drug in this class. | * [[Ketamine]] a synthetic anaesthesia, which globally, is the most prescribed drug in this class. | ||
== Usage == | == Usage == | ||
Line 55: | Line 55: | ||
''"MDMA experience reports featured an emotionally intensifying profile accompanied by many cognitive process words and dynamic-personal language. In contrast, Ayahuasca and DMT experience reports involved relatively little emotional language, few cognitive process words, increased analytical thinking-associated language, and the most semantic similarity with psychedelic and mystical experience descriptions<ref>'''Analysis of recreational psychedelic substance use experiences classified by substance.''' Adrian Hase, Max Erdmann, Verena Limbach & Gregor Hasler Psychopharmacology volume 239, pages643–659 (2022) Altmetric Metrics https://link.springer.com/article/10.1007/s00213-022-06062-3</ref>. LSD, psilocybin mushroom, and ketamine reports showed only small differences on the emotion-, analytical thinking-, psychedelic, and mystical experience-related language outcomes. Further research has concluded: “Both doses of LSD and the high dose of psilocybin produced qualitatively and quantitatively very similar subjective effects, indicating that alterations of mind that are induced by LSD and psilocybin do not differ beyond the effect duration”<ref name=":0" />.'' | ''"MDMA experience reports featured an emotionally intensifying profile accompanied by many cognitive process words and dynamic-personal language. In contrast, Ayahuasca and DMT experience reports involved relatively little emotional language, few cognitive process words, increased analytical thinking-associated language, and the most semantic similarity with psychedelic and mystical experience descriptions<ref>'''Analysis of recreational psychedelic substance use experiences classified by substance.''' Adrian Hase, Max Erdmann, Verena Limbach & Gregor Hasler Psychopharmacology volume 239, pages643–659 (2022) Altmetric Metrics https://link.springer.com/article/10.1007/s00213-022-06062-3</ref>. LSD, psilocybin mushroom, and ketamine reports showed only small differences on the emotion-, analytical thinking-, psychedelic, and mystical experience-related language outcomes. Further research has concluded: “Both doses of LSD and the high dose of psilocybin produced qualitatively and quantitatively very similar subjective effects, indicating that alterations of mind that are induced by LSD and psilocybin do not differ beyond the effect duration”<ref name=":0" />.'' | ||
For psilocybin, ketamine, mescaline and LSD it has been found that the psychedelic experience have yielded magnetoencephalographic (MEG) signals values exceeding those of normal waking consciousness. Indicating psychedelic drugs induce ‘''heightened state of consciousness''‘. The scans found the most notable effects in parts of the brain that are known to be important for perceptions, rather than other roles such as language and movement. | For [[psilocybin]], [[ketamine]], mescaline and LSD it has been found that the psychedelic experience have yielded magnetoencephalographic (MEG) signals values exceeding those of normal waking consciousness. Indicating psychedelic drugs induce ‘''heightened state of consciousness''‘. The scans found the most notable effects in parts of the brain that are known to be important for perceptions, rather than other roles such as language and movement. | ||
=== Medicinal Chemistry === | === Medicinal Chemistry === |